Personalised therapy vs. fixed duration therapy.
Salafia
A
A
D002985:Clinical Protocols; D004359:Drug Therapy, Combination; D019983:Guideline Adherence; D006801:Humans; D007917:Leprostatic Agents / Q000627:therapeutic use*; D007918:Leprosy / Q000188:drug therapy*; D014944:World Health Organization
D007917:Leprostatic Agents